← All companies

PLXS · CIK 785786

What Plexus Corp. told the SEC could break it.

As a contract manufacturer, Plexus flagged concentration on every side. Its 10 largest customers made up 49.1% of fiscal 2025 net sales, drawn from a few sectors like healthcare, industrial and aerospace-defense, while on the supply side it leans on a limited number of suppliers — and in some cases a sole provider — for the components it assembles. Geography ties it together: a large share of its operations, workforce (58.3% in APAC) and offshore cash sit in the APAC region, especially Malaysia and China, leaving it exposed to China export controls on advanced semiconductors, the terms of Mexico's IMMEX tariff program, and broader trade and currency shifts.

4 self-disclosed vulnerabilities, pulled from its own filings — each in the company’s words, with the source. This is the risk register almost nobody reads.

In its own words

What could break it.

Customer concentration

  • Top 10 customers = ~49% of net salesmedium

    Although no single customer exceeded 10% of sales, Plexus's 10 largest customers accounted for 49.1% of net sales in fiscal 2025 (47.8% in 2024) across a limited number of market sectors; loss of a major customer or program, or weakness in healthcare/industrial/aerospace-defense demand, would significantly impact net sales.

    Our 10 largest customers accounted for 49.1% and 47.8% of our net sales in fiscal 2025 and 2024, respectively.

    SEC filing →As of 2025

Geographic concentration

  • Operations, workforce & cash concentrated in APAC — particularly Malaysia (and China)medium

    A significant portion of Plexus's operations, workforce (58.3% in APAC), assets, profitability and offshore cash is concentrated in the APAC region — particularly Malaysia, with cash also held in China — exposing it to adverse economic, political, currency or trade developments in those countries and to risk around repatriating cash.

    A significant amount of our cash balances remain held outside of the U.S., with a particular concentration in Malaysia and China. A significant portion of our operations is currently located in the APAC region, particularly in Malaysia. The concentration of our operations, workforce, assets and profitability in that region exposes us to adverse developments, economic, political or otherwise, in those countries.

    SEC filing →As of 2025

Regulatory & policy

  • China export controls & Mexico IMMEX/tariff exposuremedium

    Plexus faces trade-policy risk on two fronts: changing export regulations and sanctions on advanced semiconductors/chip equipment could limit its ability to source components for and ship products to/from its China operations, while its Mexican facilities operate under the IMMEX (Maquiladora) program for reduced tariffs — leaving it exposed to changes in IMMEX, tariffs and U.S.–partner trade-protection measures.

    Our current facilities in Mexico operate under the Mexican Maquiladora (“IMMEX”) program. This program provides for reduced tariffs and eased import regulations. We could be adversely affected by changes in the IMMEX program or our failure to comply with its requirements.

Sole-source dependency

  • Limited/sole-source component suppliers for the assembly processmedium

    Plexus relies on a limited number of suppliers for many of the electronic components used in its contract-manufacturing assembly process and, in some cases, must use the sole provider of a particular component; supplier quality problems, labor disputes, shortages or financial difficulty would disrupt production for the customer programs it builds.

    we rely on a limited number of suppliers for many of the components used in the assembly process and, in some cases, may be required to use suppliers that are the sole provider of a particular component.

    SEC filing →As of 2025

The hidden graph

Who it depends on, and who depends on it.

Relationships surfaced from filings — including ones disclosed by the other side, which is how the non-obvious ones come to light.

Its customers

  • Evolv Technologies Holdings, Inc.

    On November 5, 2025, we entered into a non-exclusive contract manufacturing agreement with Plexus Corp. (“Plexus”). This shift is part of a broader supply chain strategy aimed at enhancing scalability

    Cited →
  • Blaize Holdings, Inc.

    We also have manufacturing contracts with Plexus, a contract manufacturer with a facility located in Penang, Malaysia, that provides new product intr

    Cited →
  • Harmonic Inc.

    Plexus Services Corp. (“Plexus”), which manufactures our products at its facilities in Malaysia, currently serves as our primary contract manufacturer

    Cited →

In the MyPRIA app, this is checked against the companies you actually own.

← World Watch